Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Myofibroma

• Prescription of Letrozole for Uterine Myoma
• Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma
• QL Block in Laparoscopic Myomectomy
• To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone
• A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
• Preoperative Vaginal Dinoprostone Versus Misoprostone in Abdominal Myomectomy
• Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.
• Carboprost (Hemabate) for Fibroid Resection
• Intravenous Tranexamic Acid and Intramyometrial Desmopressin Effect on Blood Loss During Laparoscopic Myomectomy.
• A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
• A Phase II/III Study of Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia With Uterine Fibroids
• A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia
• FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea
• Effect of Rectal Misoprostol in Reducing Intra-operative Blood Loss During Myomectomy
• Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy
• Comparison of Concentration of Vasopressin During Robot-assisted Laparoscopic Myomectomy
• UA Versus UAE in Treatment of Fibroids
• Composition for Treating Uterine Fibroid (PP6)
• Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy
• Dexamethasone for Post Uterine Artery Embolization Pain
• Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy
• Endometrial Preparation by Short Course of Letrozole Before Hysteroscopic Removal of Endocavitary Lesions
• Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies
• Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function
• Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy
• PREOPERATIVE GONADOTROPINE-RELEASING HORMONE AGONIST THERAPY BEFORE SURGERY FOR UTERİN FIBROIDS
• INTERVENTION WITH TRANEXAMIC ACID TO REDUCE HAEMORRHAGE DURING LAPAROSCOPIC MYOMECTOMY
• Pharmacokinetics and Hepatic Safety of EGCG
• Mechanistic Characterization of Uterine Pain
• Ulipristal Acetate in Symptomatic Uterine Fibroid
• Effect of Addition of Steroids on Duration of Analgesia
• Efficacy of Paracervical Block in Laparoscopic Myomectomy: a Randomized Controlled Trial (PALM)
• Vasopressin Injection Versus Misoprostol During Hysteroscopic Myomectomy In Reducing Blood Loss And Operation Time.
• ICG to Assess Ovarian Perfusion
• The Value of Myomectomy in Women With Intramural Myoma Before IVF.
• A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
• Paracervical Block in Laparoscopic Hysterectomy
• Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
• Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
• Association Between Vitamin D and the Risk of Uterine Fibroids
• Association Between Vitamin D and the Development of Uterine Fibroids
• The Efficacy and Safety of Preoperative Misoprostol in Blood-loss Reduction During Myomectomy.
• Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis
• the Effect of Misoprostol on Intra-operative Blood Loss During Myomectomy Operation
• A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding
• Aromatase Plus GnRH Analogue Versus Ulippristal Acetate in Uterine Fibroids
• LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
• Pharmacokinetics and Safety of Vilaprisan in Renal Impairment
• Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)
• Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)
• Effects of Simvastatin on Uterine Leiomyoma Size
• Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned
• Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids
• Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
• Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
• A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy
• Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
• A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet
• The Effect of Simvastatin on Uterine Leiomyoma Development and Growth in Infertile Women
• LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
• Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids
• Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids
• LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
• An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
• Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)
• Ulipristal Use in Chinese Population
• An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids
• Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound
• Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
• A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids
• A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids
• Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
• Fibroids in Women of Reproductive Age and Women Pregnancy
• IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF Failure
• Pilot of Letrozole for Uterine Myomas
• Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids
• Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women
• Ulipristal Acetate 10 mg and Asisted Reproduction
• Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas
• Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma
• Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids
• A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibro
• Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization
• Patient Centered Results for Uterine Fibroids
• Effectiveness of IV Acetaminophen and IV Ibuprofen in Reducing Post Procedural Pain in the UFE Procedure
• Misoprostol for Reduction of Blood Loss During Fibroid Surgery
• Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine Fibroids
• A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
• A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas
• Vascular Function and Uterine Fibroids
• AMH Levels Change During Treatment With GnRh Agonist
• Use of Dexamethasone in Uterine Artery Embolization
• Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy
• ONSD According to the Position During Laparoscopy
• GnRH Agonist Pretreatment in Hysteroscopic Myomectomy
• Vasopressin Versus Epinephrine in Myomectomy
• Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
• Mifepristone to Treat Uterine Fibroids
• Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200
• Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin
• Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma
• PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
• Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery
• Extension of Study ZPV-200
• PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
• Preemptive Analgesia Following Uterine Artery Embolization
• Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma
• Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management.
• Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids
• Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids
• Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
• Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer
• PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study)
• PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
• Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids
• A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
• An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext
• Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003
• Aromatase Inhibitors for Treatment of Uterine Leiomyomas
• Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids
• Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
• Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids
• Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms
• Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids
• Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids
• A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.
• PGL4001 Versus Placebo in Uterine Myomas
• Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids
• PGL4001 Versus GnRH-agonist in Uterine Myomas
• Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids
• Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids
• Mifepristone for Treatment of Uterine Fibroids
• Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids
• Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
• The Effect of Mifepristone on Uterine Fibroids and Breast Tissue
• Study Evaluating PRA-027 Multiple Ascending Doses In Cycling And Postmenopausal Women
• Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females
• Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)
• Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
• A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas
• A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids
• A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids
• Safety of Treatment of Uterine Fibroids With Asoprisnil
• Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids
• A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.
• Study of Asoprisnil in the Treatment of Uterine Fibroids.
• Treatment of Uterine Fibroids With Asoprisnil(J867)
• A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids
• A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy
• Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist